Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

KYTX

Kyverna Therapeutics Inc

May 01 • 04:00PM ET

8.87

+0.07 0.80 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: MRNA AMGN VRTX JNJ REGN GILD BMRN PFE BMY NVAX

| Held by: VTI VXF IBB SCHA DWAS SURI IWC AVSC PRFZ DFAS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-3.66	Insider Own	39.77%	Shs Outstand	60.39M	Perf Week	-2.10%
Market Cap	536.90M	Forward P/E	-	EPS next Y	-2.98	Insider Trans	1.02%	Shs Float	36.45M	Perf Month	1.14%
Enterprise Value	286.68M	PEG	-	EPS next Q	-0.75	Inst Own	41.87%	Short Float	11.61%	Perf Quarter	10.74%
Income	-161.31M	P/S	-	EPS this Y	16.12%	Inst Trans	23.00%	Short Ratio	5.03	Perf Half Y	23.71%
Sales	0.00M	P/B	2.31	EPS next Y	2.51%	ROA	-53.64%	Short Interest	4.23M	Perf YTD	-5.64%
Book/sh	3.85	P/C	1.92	EPS next 5Y	12.50%	ROE	-64.67%	52W High	13.67 -35.11%	Perf Year	299.55%
Cash/sh	4.61	P/FCF	-	EPS past 3/5Y	-75.86% -56.27%	ROIC	-62.68%	52W Low	1.92 361.98%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.84% 9.45%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-5.71%	Oper. Margin	-	ATR (14)	0.82	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.75	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	48.44	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	7.75	EPS Q/Q	7.59%	SMA20	-5.00%	Beta	2.06	Target Price	29.60
Payout	-	Debt/Eq	0.12	Sales Q/Q	-	SMA50	1.55%	Rel Volume	0.63	Prev Close	8.80
Employees	130	LT Debt/Eq	0.11	Earnings	Mar 26 AMC	SMA200	26.10%	Avg Volume	840.90K	Price	8.87
IPO	Feb 08, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.99% -	Trades		Volume	532,746	Change	0.80%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)